Herein we propose that the inhibition of the actin cytoskeleton regulatory protein hMENA may interrupt the communication between cancer cells and CAFs leading to an inhibition of tumor invasiveness by regulating GAS6/AXL axis and impacts PDAC and NSCLC patient prognosis. The gene discussed is AXL; the disease is non-small cell lung carcinoma.